- Pyrolate (Glycopyrrolate) Injection is indicated for use as a pre-operative anti-muscarinic to reduce salivary, tracheo-bronchial, and pharyngeal secretions and to reduce the volume of free gastric acid.
- Pyrolate (Glycopyrrolate) Injection may be used intra-operatively to counteract drug induced or vagal traction reflexes with arrhythmias.
- Pyrolate (Glycopyrrolate) Injection is indicated to reverse the neuromuscular block produced by non-depolarizing neuromuscular blocking agents such as Neostigmine.
Pyrolate®I.V Injection (Glycopyrrolate USP)
Brookes Pharma introduces this life saving Injection Pyrolate, first time in Pakistan. Pyrolate (Glycopyrrolate) is an anti-cholinergic drug. It is a synthetic quaternary ammonium compound. Glycopyrrolate inhibits the muscarinic actions of acetyl choline. Pyrolate is a potent anti – sialagogue, 4-5 times more potent than atropine. The highly polar quaternary ammonium group of glycopyrrolate limits its passage across lipid membranes, such as the blood brain barrier, in contrast to atropine sulphate and scopolamine hydrobromide, therefore devoid of undesirable central nervous system effects.
Pyrolate Injection is available in box of 10x1ml ampoules
